266 related articles for article (PubMed ID: 8417333)
1. The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth.
Finlay CA
Mol Cell Biol; 1993 Jan; 13(1):301-6. PubMed ID: 8417333
[TBL] [Abstract][Full Text] [Related]
2. A modified p53 overcomes mdm2-mediated oncogenic transformation: a potential cancer therapeutic agent.
Lin J; Jin X; Page C; Sondak VK; Jiang G; Reynolds RK
Cancer Res; 2000 Oct; 60(20):5895-901. PubMed ID: 11059788
[TBL] [Abstract][Full Text] [Related]
3. p53-plus-ras-transformed rat embryo fibroblasts express tumor-specific transplantation antigen activity which is shared by independently transformed cells.
Frey AB; Levine AJ
J Virol; 1989 Dec; 63(12):5440-4. PubMed ID: 2531235
[TBL] [Abstract][Full Text] [Related]
4. Wild-type p53 can inhibit oncogene-mediated focus formation.
Eliyahu D; Michalovitz D; Eliyahu S; Pinhasi-Kimhi O; Oren M
Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8763-7. PubMed ID: 2530586
[TBL] [Abstract][Full Text] [Related]
5. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.
Momand J; Zambetti GP; Olson DC; George D; Levine AJ
Cell; 1992 Jun; 69(7):1237-45. PubMed ID: 1535557
[TBL] [Abstract][Full Text] [Related]
6. The p53 proto-oncogene can act as a suppressor of transformation.
Finlay CA; Hinds PW; Levine AJ
Cell; 1989 Jun; 57(7):1083-93. PubMed ID: 2525423
[TBL] [Abstract][Full Text] [Related]
7. Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene.
Chen J; Lin J; Levine AJ
Mol Med; 1995 Jan; 1(2):142-52. PubMed ID: 8529093
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the proportion of p53 bound to mdm-2 in cells with defined growth characteristics.
Momand J; Zambetti GP
Oncogene; 1996 Jun; 12(11):2279-89. PubMed ID: 8649767
[TBL] [Abstract][Full Text] [Related]
9. Tolerance of high levels of wild-type p53 in transformed epithelial cells dependent on auto-regulation by mdm-2.
Blaydes JP; Gire V; Rowson JM; Wynford-Thomas D
Oncogene; 1997 Apr; 14(15):1859-68. PubMed ID: 9150392
[TBL] [Abstract][Full Text] [Related]
10. Nuclear localization is essential for the activity of p53 protein.
Shaulsky G; Goldfinger N; Tosky MS; Levine AJ; Rotter V
Oncogene; 1991 Nov; 6(11):2055-65. PubMed ID: 1719467
[TBL] [Abstract][Full Text] [Related]
11. Abrogation of wild-type p53 mediated growth-inhibition by nuclear exclusion.
Knippschild U; Oren M; Deppert W
Oncogene; 1996 Apr; 12(8):1755-65. PubMed ID: 8622896
[TBL] [Abstract][Full Text] [Related]
12. The p53 tumor suppressor gene and gene product.
Levine AJ
Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
[TBL] [Abstract][Full Text] [Related]
13. Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation.
Hinds P; Finlay C; Levine AJ
J Virol; 1989 Feb; 63(2):739-46. PubMed ID: 2642977
[TBL] [Abstract][Full Text] [Related]
14. mdm-2 oncogene expression in non-Hodgkin's lymphomas.
Kawamata N; Miller C; Levy V; Shintaku IP; Koeffler HP; Said JW
Diagn Mol Pathol; 1996 Mar; 5(1):33-8. PubMed ID: 8919543
[TBL] [Abstract][Full Text] [Related]
15. The p53-mdm-2 autoregulatory feedback loop.
Wu X; Bayle JH; Olson D; Levine AJ
Genes Dev; 1993 Jul; 7(7A):1126-32. PubMed ID: 8319905
[TBL] [Abstract][Full Text] [Related]
16. Large E1B proteins of adenovirus types 5 and 12 have different effects on p53 and distinct roles in cell transformation.
van den Heuvel SJ; van Laar T; The I; van der Eb AJ
J Virol; 1993 Sep; 67(9):5226-34. PubMed ID: 8350396
[TBL] [Abstract][Full Text] [Related]
17. mdm-2 expression correlates with wild-type p53 status in esophageal adenocarcinoma.
Soslow RA; Altorki NK; Yang G; Xie D; Yang CS
Mod Pathol; 1999 Jun; 12(6):580-6. PubMed ID: 10392633
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer.
Sjöström J; Blomqvist C; Heikkilä P; Boguslawski KV; Räisänen-Sokolowski A; Bengtsson NO; Mjaaland I; Malmström P; Ostenstadt B; Bergh J; Wist E; Valvere V; Saksela E
Clin Cancer Res; 2000 Aug; 6(8):3103-10. PubMed ID: 10955790
[TBL] [Abstract][Full Text] [Related]
19. Cell-specific transcriptional activation of the mdm2-gene by ectopically expressed wild-type form of a temperature-sensitive mutant p53.
Knippschild U; Kolzau T; Deppert W
Oncogene; 1995 Aug; 11(4):683-90. PubMed ID: 7651732
[TBL] [Abstract][Full Text] [Related]
20. The mdm2 proto-oncogene.
Haines DS
Leuk Lymphoma; 1997 Jul; 26(3-4):227-38. PubMed ID: 9322885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
